These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28006849)

  • 1. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
    Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
    Am J Hematol; 2017 Mar; 92(3):251-258. PubMed ID: 28006849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark.
    Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; de Nully Brown P; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
    Cancer Med; 2019 Aug; 8(10):4918-4927. PubMed ID: 31264807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators.
    Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Björkholm M; Lambert PC; Dickman PW; Glimelius I
    J Clin Oncol; 2018 Sep; 36(26):2718-2725. PubMed ID: 30044694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors.
    de Fine Licht S; Rugbjerg K; Gudmundsdottir T; Bonnesen TG; Asdahl PH; Holmqvist AS; Madanat-Harjuoja L; Tryggvadottir L; Wesenberg F; Hasle H; Winther JF; Olsen JH;
    PLoS Med; 2017 May; 14(5):e1002296. PubMed ID: 28486495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
    Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
    J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.
    Glimelius I; Ekberg S; Jerkeman M; Chang ET; Björkholm M; Andersson TM; Smedby KE; Eloranta S
    Am J Hematol; 2015 Dec; 90(12):1128-34. PubMed ID: 26349012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
    Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
    Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.
    Rugbjerg K; Maraldo M; Aznar MC; Cutter DJ; Darby SC; Specht L; Olsen JH
    Int J Cancer; 2017 May; 140(10):2232-2245. PubMed ID: 28213927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).
    Eloranta S; Lambert PC; Sjöberg J; Andersson TM; Björkholm M; Dickman PW
    J Clin Oncol; 2013 Apr; 31(11):1435-41. PubMed ID: 23439756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.
    Nord C; Olofsson SE; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Ståhl E; Neovius M; Jerkeman M; Smedby KE
    Acta Oncol; 2015 Nov; 54(10):1770-80. PubMed ID: 25833328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study.
    Øvlisen AK; Jakobsen LH; Eloranta S; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Dahl-Sørensen RB; Stoltenberg D; Weibull CE; Entrop JP; Glimelius I; Smedby KE; Torp-Pedersen C; Severinsen MT; El-Galaly TC
    J Clin Oncol; 2021 Nov; 39(31):3463-3472. PubMed ID: 34170749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma.
    Weibull CE; Eloranta S; Smedby KE; Björkholm M; Kristinsson SY; Johansson AL; Dickman PW; Glimelius I
    J Clin Oncol; 2016 Feb; 34(4):337-44. PubMed ID: 26668344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
    Weibull CE; Björkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
    Int J Cancer; 2019 Sep; 145(5):1200-1208. PubMed ID: 30666628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.